title: The randomized registry trial--the next disruptive technology in clinical research?
authors.affiliation: From the Office of the Director, Division of Cardiovascular Sciences, the National Heart, Lung, and Blood Institute, Bethesda, MD (M.S.L.); and the Mathematics and Statistics Department, Boston University, and the Harvard Clinical Research Institute - both in Boston (R.B.D.).
authors.forename: Michael S
authors.initials: MS
authors.lastname: Lauer
authors.forename: Ralph B
authors.initials: RB
authors.lastname: D'Agostino
mesh_terms: D057186:Comparative Effectiveness Research; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D012042:Registries